<div class="container">

<table style="width: 100%;"><tr>
<td>CVfromCI</td>
<td style="text-align: right;">R Documentation</td>
</tr></table>
<h2>CV from a given Confidence interval</h2>

<h3>Description</h3>

<p>Calculates the CV (coefficient of variation) from a known confidence interval
of a BE study.<br> 
Useful if no CV but the 90% CI was given in literature.
</p>


<h3>Usage</h3>

<pre><code class="language-R">CVfromCI(pe, lower, upper, n, design = "2x2", alpha = 0.05, robust = FALSE)
CI2CV(pe, lower, upper, n, design = "2x2", alpha = 0.05, robust = FALSE)
</code></pre>


<h3>Arguments</h3>

<table>
<tr style="vertical-align: top;">
<td><code>pe</code></td>
<td>

<p>Point estimate of the T/R ratio.<br>
The <code>pe</code> may be missing. In that case it will be calculated as geometric 
mean<br>
of <code>lower</code> and <code>upper</code>.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>lower</code></td>
<td>

<p>Lower confidence limit of the BE ratio.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>upper</code></td>
<td>

<p>Upper confidence limit of the BE ratio.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>n</code></td>
<td>

<p>Total number of subjects under study if given as scalar.<br>
Number of subjects in (sequence) groups if given as vector.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>design</code></td>
<td>

<p>Character string describing the study design.<br>
See <code>known.designs()</code> for designs covered in this package.
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>alpha</code></td>
<td>

<p>Error probability. Set it to <code>(1-confidence)/2</code> (<em>i.e.</em> to 0.05 for the usual 90% confidence intervals).
</p>
</td>
</tr>
<tr style="vertical-align: top;">
<td><code>robust</code></td>
<td>

<p>With <code>robust=FALSE</code> (the default) usual degrees of freedom of the designs are used.<br>
With <code>robust=TRUE</code> the degrees of freedom for the so-called robust
evaluation (df2 in known.designs()) will be used. This may be helpful
if the CI was evaluated via a mixed model or via intra-subject contrasts 
(aka Senn’s basic estimator).
</p>
</td>
</tr>
</table>
<h3>Details</h3>

<p>See Helmut Schütz’ <a href="https://bebac.at/lectures/Bucharest2013WS1.pdf#page=26">presentation</a> for the algebra underlying this function.
</p>


<h3>Value</h3>

<p>Numeric value of the CV as ratio.
</p>


<h3>Note</h3>

<p>The calculations are based on the assumption of evaluation via log-transformed values.<br>
The calculations are further based on a common variance of Test and Reference 
treatments in replicate crossover studies or parallel group study, respectively.<br><br>
In case of argument <code>n</code> given as n(total) and is not divisible by the number
of (sequence) groups the total sample size is partitioned to the (sequence) groups
to have small imbalance only. A message is given in such cases.<br>
The estimated CV is conservative (<em>i.e.</em>, higher than actually observed) in case of 
unbalancedness.<br><br><code>CI2CV()</code> is simply an alias to <code>CVfromCI()</code>.
</p>


<h3>Author(s)</h3>

<p>Original by D. Labes with suggestions by H. Schütz.<br>
Reworked and adapted to unbalanced studies by B. Lang.</p>


<h3>References</h3>

<p>Yuan J, Tong T, Tang M-L. <em>Sample Size Calculation for Bioequivalence Studies Assessing Drug Effect and Food Effect at the Same Time With a 3-Treatment Williams Design.</em> Regul Sci. 2013;47(2):242–7. <a href="https://doi.org/10.1177/2168479012474273">doi:10.1177/2168479012474273</a>
</p>


<h3>Examples</h3>

<pre><code class="language-R"># Given a 90% confidence interval (without point estimate) 
# from a classical 2x2 crossover with 22 subjects
CVfromCI(lower=0.91, upper=1.15, n=22, design="2x2")
# will give [1] 0.2279405, i.e a CV ~ 23%
#
# unbalanced 2x2 crossover study, but not reported as  such
CI2CV(lower=0.89, upper=1.15, n=24)
# will give a CV ~ 26.3%
# unbalancedness accounted for
CI2CV(lower=0.89, upper=1.15, n=c(16,8))
# should give CV ~ 24.7%
</code></pre>


</div>